首页> Gynecologic oncology> Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN).

Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN).

导出 LinkOut

翻译打印收藏纠错

第一作者： Matthew C,Winter

第一单位： Sheffield Centre for Trophoblastic Disease, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Whitham Road, Sheffield S10 2SJ, UK; Department of Oncology and Metabolism, The University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK. Electronic address: matthewwinter@nhs.net.

作者： Matthew C,Winter ^[1] ; John A,Tidy ^[2] ; Kam,Singh ^[2] ; Naveed,Sarwar ^[3] ; Xianne,Aguiar ^[3] ; Michael J,Seckl ^[3]

作者单位： Sheffield Centre for Trophoblastic Disease, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Whitham Road, Sheffield S10 2SJ, UK; Department of Oncology and Metabolism, The University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK. Electronic address: matthewwinter@nhs.net. ^[1] Sheffield Centre for Trophoblastic Disease, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Whitham Road, Sheffield S10 2SJ, UK. ^[2] Gestational Trophoblastic Tumour Centre, Charing Cross Hospital Campus of Imperial College London, Fulham Palace Rd, London W6 8RF, UK. ^[3]

关键词 Carboplatin Gestational trophoblastic neoplasia Low-risk Methotrexate-resistance Second-line chemotherapy